#USA #Indianapolis #NewVale Capital #JLL Partners #CAI

CAI Completes Strategic Recapitalization with JLL Partners

On July 2, 2026, CAI, a prominent professional services firm specializing in operational readiness and excellence within life sciences and mission-critical environments, announced the successful completion of its recapitalization with JLL Partners. JLL, a New York-based private equity firm focused on middle-market investments in healthcare, industrials, and business services, will foster CAI's ambitious growth trajectory.

This strategic partnership comes at a time when CAI is already seeing promising developments, including an enhanced service offering for global clients in Australia and new technology partnerships. With JLL's backing, CAI aims to accelerate its investments in talent, training, next-generation technologies, strategic acquisitions, and expanded service offerings, all while nurturing its culture as the employer of choice for skilled professionals in heavily regulated and mission-critical industries.

For more than 30 years, CAI has been providing operational readiness services to critical industrial clients, demonstrating the technical precision and diligence required in their environments. The collaboration with JLL is poised to build upon the extensive expertise and long-standing client relationships held by CAI's expert team of over 700 professionals across North America, Europe, Australia, and Asia.

According to Sheena Dempsey, CEO of CAI, “With the completion of this transaction, we’ve realized our goal of establishing a strong partnership with JLL, allowing us to improve and expand our service offerings while unlocking new technologies, regions, and services.” She noted that the partnership is fundamentally about the support JLL provides for CAI's business strategy and its vision for the future.

CAI’s CFO, Phil Pursifull, expressed excitement about the company's future, stating, “Having been a part of CAI for nearly three decades, this is one of the most thrilling moments in our history. We are experiencing robust customer demand, continuously advancing across all technologies, while enjoying substantial opportunities to invest in our employees and our unique corporate culture.”

NewVale Capital, a growth equity firm specializing in investments in life sciences service companies, acted as an investment partner in this transaction. Bourne Partners and Stifel served as financial advisors for JLL Partners, while Stout acted as financial advisors for CAI.

About CAI

CAI is a professional services firm comprised of experts in engineering, quality assurance, and operational performance, dedicated to enhancing operational readiness and excellence within life sciences and mission-critical environments. With deep roots in Commissioning, Qualification, and Validation (CQV), CAI has evolved alongside the industries it serves over the last three decades, helping businesses safely bring complex facilities, systems, and technologies online.

CAI's top-tier team blends profound technical expertise with proven processes and modern tools to deliver projects on time and within budget, achieving impactful results in highly regulated environments. For over thirty years, CAI has embraced innovative methods, assisting its clients in navigating digital transformations while simultaneously enhancing operational readiness. Amid rising industry demands, CAI is positioned to define the next era of agility, resilience, and operational excellence.

For more information, visit CAI's website.

About JLL Partners

JLL Partners, LLC is a private equity firm specializing in middle-market investments with over three decades of experience in transforming healthcare, industrial, and business services companies. JLL focuses on forging partnerships with companies it believes can evolve into market leaders through a blend of strategic mergers and acquisitions, organic growth initiatives, and operational enhancements. The experienced investment professionals and operating partners at JLL drive long-term value creation across their portfolio.

Since its founding in 1988, JLL Partners has invested approximately $9 billion in equity across 61 platform investments. For additional details, visit www.jllpartners.com.

About NewVale Capital

Founded in 2021, NewVale Capital is a growth equity firm specialized in the pharmaceutical sector, investing in established, revenue-generating service and technology companies within the life sciences ecosystem. More information can be found at www.newvalecapital.com.